Blue Sail Medical recently introduced the situation of introducing foreign industrial investors to its subsidiary through capital increase and share expansion in a telephone conference. In the current economic situation, Thai industrial investors, represented by HKG, chose Shandong Health Technology, a competitive subsidiary of Blue Sail Medical, as a long-term strategic investment, which has a significant impact on the gloves industry.
蓝帆医疗：预估可以新建100亿支-150亿支/年的生产线
Blue Sail Medical: estimated to be able to build 10-15 billion new production lines per year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.